Consequently, the effect of pharmacological inhibition of CPT1 by etomoxir was evaluated in the experimental autoimmune encephalomyelitis (EAE) animal model of MS (Fig. 1a). This evidence concerns the gene CPT1A and myeloid sarcoma.